Michele Stanchina

University of Miami Health System

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Justin Taylor

University of Miami

UNITED STATES

View details

Yiqin Zuo

Assistant Professor

University of Miami Hospital

UNITED STATES

View details

Dai Chihara

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jose Augusto Monteiro de Oliveira Novaes

Assistant Professor

Winship Cancer Institute of Emory University

UNITED STATES

View details

Sunil Iyer

Columbia University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michele Stanchina

Research Interests

Explore related searches

Contact this professor

Articles (9)

Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study

The rare phenomenon of glomerulonephritis presentation in extra-nodal marginal zone lymphoma: summary of two cases and review of the literature

Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia

The treatment of acute promyelocytic leukemia in 2023: Paradigm, advances, and future directions.

Prevalence and Outcomes of COVID-19 among Hematology/Oncology Patients and Providers of a Community-Facing Health System during the B1.1.529 (“Omicron”) SARS-CoV-2 Variant Wave

Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date.

Current State and Challenges in Development of Targeted Therapies in Myelodysplastic Syndromes (MDS)

Advances in Acute Myeloid Leukemia: Recently Approved Therapies and Drugs in Development

BCR-ABL tyrosine kinase inhibitor (TKI)-induced nephropathy: An under-recognized phenomenon.

Collaborators (5)

Justin Taylor

Yiqin Zuo

Dai Chihara

Jose Augusto Monteiro de Oliveira Novaes

Sunil Iyer

Make your next move.